Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 2, 2024Meditsinskiy sovet = Medical CouncilOpen Access

Tofacitinib as a means of optimizing the treatment of rheumatoid arthritis at the outpatient stage (clinical cases)

View Full Paper
Ask AI
Bookmark
Share

Authors

IBI. B. BashkovaIMI. V. Madyanov

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bashkova et al. (2024) studied this question.

synapsesocial.com/papers/68e6bd3bb6db64358763d628https://doi.org/10.21518/ms2024-083
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tofacitinib in rheumatoid arthritis: what is new?2020 · 2 citations
  2. 2Efficacy and safety of tofacitinib for treatment of rheumatoid arthritis2014 · 46 citations
  3. 3Tofacitinib: efficiency and safety in long-term use2019 · 2 citations
  4. 4Evaluation of the effectiveness of Tofacitinib in rheumatoid arthritis in real clinical practice: The relationship between pain relief in the first 4 weeks and disease activity after 3–6 months2021 · 5 citations
  5. 5Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques2016 · 101 citations